Pituitary & hypothalamus

Tall stature and gigantism in adult patients with acromegaly

Eur J EndocrinolPublished Observational study

Authors' conclusion

In a group of 135 consecutive adult patients with acromegaly, 23% had increased height based on country-specific and MPH data: 13% presented with gigantism while 10% had TS. The frequency of gigantism and TS in patients diagnosed with GH excess as adults is not higher in males than in females. Patients with acromegaly come from normal-stature families.

Study context

Population
Adults diagnosed with acromegaly, no family history of growth hormone (GH) excess
Participants
135 consecutive patients
Outcome
Height of adult patients with GH excess relative to mid-parental height (MPH) and population mean; categories: normal stature, TS, gigantism
Methodological detailssingle-centre, consecutive patients
  • Single-centre
  • Consecutive patients

Main finding

As reported in the abstract

Height categories

Gigantism (53% females)

13%

17/135

Tall stature (TS) (57% females)

10%

14/135

Increased height (gigantism or TS)

23%

Observational data: associations, not effects.

Further findings

Height of parents and adult siblings

Parents and adult siblings were not taller than the population mean

Original publication

Tall stature and gigantism in adult patients with acromegaly. Eur J Endocrinol. Published 23 February 2024. doi:10.1093/ejendo/lvae019

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.